The effects of 10-day complete fasting on human health and metabolism

ISRCTN ISRCTN17045897
DOI https://doi.org/10.1186/ISRCTN17045897
Secondary identifying numbers SMFA17A02
Submission date
17/05/2022
Registration date
24/05/2022
Last edited
06/10/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Background and study aims
Fasting is beneficial to many aspects of human health and shows great potential for the treatment of chronic metabolic diseases. The aim of this study is to investigate the safety and the effects on metabolism and health of prolonged water-only fasting. The study's findings should provide evidence to design a new fasting therapeutic strategy for clinical practice.

Who can participate?
Healthy men aged 25 to 55 years with body mass index (BMI) from 19 to 32 kg/m²

What does the study involve?
Participants are recruited and must pass a health examination. The whole experiment lasted 22 days including a 3-day baseline (BL), 10-day complete fasting (CF), 4-day calorie restriction diet (CR) and 5-day full recovery diet (FR) in a controlled building. During the CF period, participants are only permitted to drink water when they want and perform normal activities in the lab building. In the CR phase, the participants are given gradually increased amounts of food to protect their digestive system after CF. During the FR phase, the participants are allowed to return to their normal eating habits. Bodyweight, resting blood pressure and pulse, blood glucose and ketones (β-hydroxybutyrate) are monitored every day in CF and CR. Blood, urine and feces will be collected for routine tests and to measure metabolism, hormones and cytokines at six timepoints including one time before CF, three times during CF, one time during CR and one time in FR. Questionnaires about psychological mood are taken at the same times. Resting metabolic rate will be measured at five timepoints (before, twp times during and two times after).

What are the possible benefits and risks of participating?
There is no economic benefit, but fasting may help to improve health, and the results will help to design new fasting modes even for spaceflight. The main risk is low blood glucose, which will be monitored every day and at any time needed. The whole study will be conducted under medical supervision.

Where is the study run from?
Space Science and Technology Institute (China)

When is the study starting and how long is it expected to run for?
January 2018 to June 2018

Who is funding the study?
1. State Key Laboratory of Space Medicine Fundamentals and Application and the China Astronaut Research and Training Center (China)
2. Advanced Space Medico-Engineering Research Project of China (China)
3. Space Medical Experiment Project of China Manned Space Program (China)

Who is the main contact?
Zhongquan Dai
daizhq77@163.com

Contact information

Prof Zhongquan Dai
Principal Investigator

No.26, Beiqing Road
Haidian District
Beijing
100094
China

ORCiD logoORCID ID 0000-0002-6152-6407
Phone +86 (0)13683338750
Email daizhq77@163.com

Study information

Study designInterventional case series
Primary study designInterventional
Secondary study design
Study setting(s)Other
Study typeOther
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleThe effects of 10-day complete fasting hypometabolism on human health and homeostasis
Study hypothesisBased on Chinese traditional health methods, in this human experiment fasting was used to change metabolism in order to explain the change pattern and switch time window of energy substrate utilization (glucose-fat-protein), the metabolic change of tissue organ functions such as liver, fat, and intestinal microecology, and the alteration of regulating hormones to appetite, blood sugar, lipid metabolism and others, and to explore the feasibility of using fasting to induce and maintain a hypometabolic state during spaceflight.
Ethics approval(s)Approved 02/05/2018, Biomedical Research Ethics Committee Involving People of the Space Science and Technology Institute (4 Shamiao Road, Longgang District, Shenzhen, Guangdong, China; +86 (0)13688832866; 312506571@qq.com), ref: not applicable
ConditionEffects of complete fasting on human health and metabolism
Intervention10-day water-only fasting in a controlled building including 3-day baseline (BL), 10-day complete fasting (CF), 4-day calorie restriction (CR) and 5-day full recovery (FR). Health status is assessed by monitoring pulse, blood pressure, body weight (BW), blood glucose and ketone, nutritional indices, body composition and biochemistry indexes at different times. Blood, urine and feces are collected to further analyze hormones, cytokines, and intestinal microecology.
Intervention typeBehavioural
Primary outcome measure1. Body weight is measured by an electric scale every day throughout the study
2. Blood pressure is measured by an electronic blood pressure monitor every day throughout the study
3. Blood glucose and ketone determined by test strip every day or by a biochemistry method at six timepoints (3 days before fasting, the 3rd day, 6th day and 9th day during fasting, 3 days and 8 days after resuming diet) in hospital
4. Urine acid is measured by biochemistry method in hospital at six timepoints (3 days before fasting, the 3rd day, 6th day and 9th day during fasting, 3 days and 8 days after resuming diet)
5. Body compostion measured by dual-energy X-ray absorptiometry (DEXA) or sfb7 at three timepoints (3 days before fasting, 6th day during fasting 10 days after resuming diet)
6. Blood routine examination in hospital at six timepoints (3 days before fasting, the 3rd day, 6th day and 9th day during fasting, 3 days and 8 days after resuming diet)
7. Psychological mood is measured using the Profle of Mood State (POMS), Visual Analogue Scales (VAS), Self-rating Anxiety Scale (SAS), Self-rating Depression Scale (SDS), Work Ability Index (WAI), Stanford Sleepiness Scale (SSS) at six timepoints (3 days before fasting, the 3rd day, 6th day and 9th day during fasting, 3 days and 8 days after resuming diet
Secondary outcome measures1. Hormones and cytokines measured by ELISA or biochemistry at six timepoints (3 days before fasting, the 3rd day, 6th day and 9th day during fasting, 3 days and 8 days after resuming diet)
2. Resting metabolic rate is measured by indirect calorimetry at five timepoints (2 days before fasting, 3rd and 9th day during fasting, 3 days and 7-8 days after resuming diet)
Overall study start date01/01/2018
Overall study end date08/06/2018

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
SexMale
Target number of participants14
Total final enrolment13
Participant inclusion criteria1. Healthy male
2. 25-55 years old
3. BMI 20-32 kg/m²
Participant exclusion criteria1. Malignant tumor
2. Serious cardiovascular diseases (congenital heart disease, myocardial infarction, coronary heart disease, angina pectoris, etc)
3. Infectious disease
4. Mental disorders
5. Anemia
6. Hypotension
7. Diabetes mellitus
8. History of gastrointestinal ulcer
9. Other after medical examination
Recruitment start date03/05/2018
Recruitment end date10/05/2018

Locations

Countries of recruitment

  • China

Study participating centre

Space Science and Technology Institute
4 Shamiao Road
Longgang District
Shenzhen
518117
China

Sponsor information

State Key Laboratory of Space Medicine Fundamentals and Application and the China Astronaut Research and Training Center
Research organisation

No.26, Beiqing Road, Haidian District
Beijing
100094
China

Phone +86 (0)13501332556
Email skl_acc@126.com

Funders

Funder type

Research organisation

State Key Laboratory of Space Medicine Fundamentals and Application, China Astronaut Research and Training Center (SMFA17A02, SMFA18B02, SMFA18B06, SMFA19C01, SMFA19C03)
Government organisation / National government
Location
China
Science, Technology and Innovation Commission of Shenzhen Municipality 2020 Basic Research Project (JCYJ20200109110630285).
Government organisation / Local government
Alternative name(s)
Shenzhen Science and Technology Innovation Commission, Shenzhen Science and Technology Innovation Committee, 深圳市科技创新委员会
Location
China
Advanced Space Medico-Engineering Research Project of China (18035020103)

No information available

Space Medical Experiment Project of China Manned Space Program (HYZHXM01002)

No information available

Results and Publications

Intention to publish date23/12/2022
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planThe researchers plan to publish in an international peer-reviewed journal.
IPD sharing planData requests should be sent to Zhongquan Dai (daizhq77@163.com). The researchers will provide all the data after they have been published in a journal. Any researcher interested in prolonged fasting can request the data, but not the private data of volunteers by email, if they demonstrate their previous research.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 03/01/2021 19/05/2022 Yes No
Results article 19/05/2021 19/05/2022 Yes No
Results article 18/09/2022 06/10/2022 Yes No

Editorial Notes

06/10/2022: Publication reference added.
19/05/2022: Trial's existence confirmed by the Biomedical Research Ethics Committee Involving People of the Space Science and Technology Institute.